Experimental studies have shown the beneficial actions on the kidney attributed to TNF-ɑ inhibition; however, these are at present limited to pentoxifylline administration in patients with chronic kidney disease because of its significant beneficial effects. This evidence concerns the gene TNF and chronic kidney disease.